Chai et al. identified miR-216a-5p as a tumor suppressor in ESCC cells by negatively regulating TCTN1 expression, indicating that miR-216a-5p and TCTN1 may serve as promising targets for ESCC therapeutic interventions (Chai and Yang, 2019). Here, TCTN1 is linked to neoplasm.